Explore
Search results
The COVID-19 pandemic forced the world to grapple with a long-standing truth: that poor diversity in early and late stage medical research remains a major threat to health equity. Overcoming barriers and challenges to fair representation in research and development will not happen overnight, nor can it be achieved by a single institution. In order to pioneer lasting and su...
Eighteen months after a COVID-19 vaccine became available, high-income countries had administered more than 200 doses per 100 people; in low-income countries, the figure was almost 90 percent less. Access to diagnostics and therapies has been likewise constricted, underscoring the imperative of new approaches to global health equity. Investing in local manufacturing and sc...
Nothing demonstrates that health is an industry ripe for growth and change more clearly than the enthusiastic participation of venture capitalists. Far more than in the past, they are committing resources to seed start-up operations, not only in artificial intelligence and data science, but also in the life sciences and health-related services and delivery systems. Recogni...